Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04568122 · ClinicalTrials.gov registry record · NA
Rapid Turnaround, Home-based Saliva Testing for COVID-19
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,277
- Enrollment target
NCT04568122: Completed NA study, sponsored by Stanford University.
NCT04568122 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,277 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04568122, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,277 participants
- Enrollment target
Study Summary
The aim of the study is to demonstrate the feasibility and validity of a saliva based home surveillance monitoring test for SARS-CoV-2 infection. Participants will be asked to carry out as many tests as are included in the bag they are provided, on a daily basis until they are used up.
Interventions
- DEVICE Saliva test kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,277 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2022-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04568122
The ClinicalTrials.gov registry entry for NCT04568122 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,277 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Saliva test kit is the first listed.
NCT04568122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04568122 about?
NCT04568122 is a clinical study titled "Rapid Turnaround, Home-based Saliva Testing for COVID-19". The aim of the study is to demonstrate the feasibility and validity of a saliva based home surveillance monitoring test for SARS-CoV-2 infection. Participants will be asked to carry out as many tests as are included in the bag they are provided, on a daily basis until they are used up.
What is the current status of trial NCT04568122?
This trial is currently completed. It is a NA study. The enrollment target is 1,277 participants. The study started on 2020-11-20. Estimated completion is 2022-12-10.
What interventions are being tested in trial NCT04568122?
The interventions under investigation include: Saliva test kit (DEVICE).
Who is sponsoring clinical trial NCT04568122?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.